IS THE OCCURRENCE OF GESTATIONAL DIABETES MELLITUS IN PREGNANCIES HIGHER FOLLOWING IN VITRO FERTILIZATION TREATMENT? WHY? A RETROSPECTIVE COHORT STUDY (Retracted article. See vol. 7, pg. 553, 2023)

---

Atıf İçin Kopyala

Akbag N. N. A., ALUŞ TOKAT M., Ozoztuerk S., AVDAL E. Ü., OKYAY R. E., DOĞAN Ö. E.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, sa.1, ss.94-102, 2023 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Basım Tarihi: 2023
• Doi Numarası: 10.30621/jbachs.1084860
• Dergi Adı: JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.94-102
• Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk.Material and Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002-2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed.Results: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36-40 at conception during the IVF cycle than the age group 31-35 (95% CI = 1.18-17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07-11.23, p= .038). Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.